I am on tirzepatide (Mounjaro) and have rapid weight loss with back and leg pain/stiffness—could this be sciatica, peroneal nerve compression/neuropathy, a vitamin deficiency, or another issue, and should I continue, hold, or avoid increasing the dose, and what tests and nutrition/protein plan are recommended?

Back and Leg Pain on Tirzepatide: Evaluation and Management

Hold your current dose of Mounjaro and do not escalate until you undergo proper evaluation, as your symptoms may represent peroneal nerve compression from rapid weight loss—a recognized complication called "slimmer's paralysis"—or other serious conditions requiring immediate assessment.

Understanding Your Symptoms

Your back and leg pain/stiffness during rapid weight loss on tirzepatide requires urgent differentiation between several possible causes:

Most Likely: Peroneal Nerve Neuropathy ("Slimmer's Paralysis")

• Rapid weight loss with GLP-1/GIP agonists like tirzepatide can cause peroneal nerve compression, typically developing within 6-8 months of treatment initiation 1
• This occurs when fat padding around the fibular head (outer knee area) is lost quickly, exposing the superficial peroneal nerve to compression 1
• Tirzepatide causes 15-20% body weight reduction, with approximately 25% of total weight loss coming from lean mass 2
• Case reports specifically document bilateral foot drop developing in patients on tirzepatide after rapid weight loss 1, 3

Other Serious Considerations

Vitamin/Nutritional Deficiencies:

• Rapid weight loss and GI side effects (nausea, vomiting, diarrhea affecting 25-35% of patients) can cause malabsorption 4
• Vitamin deficiencies (particularly B vitamins, vitamin E) are established risk factors for peripheral neuropathy 5
• Fat-soluble vitamin deficiencies (A, D, E, K) occur with reduced fat intake during aggressive weight management 6, 7

Musculoskeletal Complications:

• Rhabdomyolysis has been reported with tirzepatide, presenting as severe muscle pain and stiffness 8
• Rapid lean mass loss (up to 39% of total weight loss with similar agents) can cause muscle weakness and pain 2

Sciatica/Radiculopathy:

• Your symptoms could represent lumbar radiculopathy, though this would be coincidental rather than medication-related 9

Immediate Medication Management

Hold dose escalation and consider temporary discontinuation 10:

• The FDA label for Mounjaro states to report severe or persistent symptoms to your healthcare provider 10
• Serious adverse events requiring drug discontinuation occurred in 2.29 times more patients on tirzepatide versus placebo 11
• Most tirzepatide-associated adverse reactions occur within 1-6 months of initiation, with the highest frequency at 2.5-5 mg doses 3

Required Diagnostic Workup

Neurological Evaluation (Priority)

• Physical examination focusing on: foot dorsiflexion strength, ankle reflexes, sensory testing along peroneal nerve distribution, gait assessment 12, 1
• Nerve conduction studies and EMG if peroneal neuropathy suspected 1
• Assess for foot drop (inability to lift front of foot) which is the hallmark of peroneal nerve injury 1

Laboratory Testing

Essential blood work:

• Vitamin B12, folate, vitamin B1 (thiamine), vitamin B6 - deficiencies cause peripheral neuropathy 5
• Vitamin E levels (express as ratio to lipids) - deficiency causes balance disorders, peripheral neuropathy, muscle weakness 7
• Vitamin D, calcium, phosphorus - for bone health during rapid weight loss 7
• Creatine kinase (CK) - to rule out rhabdomyolysis 8
• Comprehensive metabolic panel - assess kidney function (tirzepatide can cause dehydration-related kidney injury) 10
• Liver function tests - acute liver injury reported with tirzepatide 3

Imaging (If Indicated)

• Lumbar spine MRI only if radicular symptoms suggest nerve root compression (pain radiating down leg in dermatomal pattern, positive straight leg raise) 9
• Consider if symptoms don't fit peroneal neuropathy pattern

Nutrition and Protein Plan

Protein Requirements

Aim for 1.2-1.6 g/kg ideal body weight daily to preserve lean mass during weight loss 2:

• Distribute protein evenly across meals (25-30g per meal)
• Prioritize high-quality protein sources: lean meats, fish, eggs, dairy, legumes
• Consider protein supplementation if unable to meet targets through food

Micronutrient Supplementation

Daily supplementation while on tirzepatide 6, 4, 7:

• Multivitamin with minerals (essential given reduced food intake)
• Vitamin B-complex (B1, B6, B12) - critical for nerve health 5
• Vitamin E 15 mg (a-tocopherol) - for neuropathy prevention 7
• Vitamin D 600-800 IU minimum 7
• Calcium 1000-1200 mg daily (split doses for better absorption)

Dietary Modifications

To minimize GI side effects and optimize nutrition 4:

• Eat smaller, frequent meals (5-6 per day)
• Increase dietary fiber gradually
• Avoid high-fat and spicy foods
• Stay well-hydrated (8-10 glasses water daily) to prevent dehydration-related complications 10
• Eat slowly and stop when feeling full
• Limit alcohol and carbonated beverages

When to Resume or Continue Tirzepatide

Do not resume or escalate dose until:

1. Neurological evaluation completed and peroneal neuropathy ruled out or stabilized 1
2. Vitamin deficiencies identified and corrected 5
3. Rhabdomyolysis excluded (normal CK) 8
4. Adequate protein intake established (>1.2 g/kg/day) 2

If continuing tirzepatide after clearance:

• Slow or pause dose escalation - consider maintaining current effective dose rather than escalating 3
• Most adverse events occur with dose escalation 4
• Implement resistance training 2-3x/week to preserve lean mass 2
• Monthly monitoring of weight, symptoms, and nutritional status

Red Flags Requiring Emergency Evaluation

Seek immediate medical attention if you develop 10:

• Severe abdominal pain (pancreatitis risk)
• Inability to lift foot/feet (foot drop)
• Progressive weakness or numbness
• Dark urine with muscle pain (rhabdomyolysis)
• Severe dehydration symptoms
• Allergic reactions (swelling, difficulty breathing)

Clinical Considerations

The American Diabetes Association recommends GLP-1/GIP agonists as preferred agents for obesity, but this must be balanced against individual risk factors 4. Your rapid weight loss, while therapeutically beneficial for metabolic health, has created mechanical and nutritional complications requiring intervention before continuing therapy 2, 1.

Gabapentin may provide symptomatic relief if neuropathic pain confirmed (small short-term benefits for radiculopathy), though this addresses symptoms rather than the underlying cause 9, 13.